Convenzione HT: first round of consultations underway
The Convenzione signed on 30 December 2020 between the Ministry of Economy and Finance, the Ministry of Health, the Ministry of University and Research and the Human Technopole Foundation regulates the creation of National Facilities (NFs) at HT, to be made available to the Italian scientific community to conduct high quality research in their respective fields, independent of institutional affiliation.
The Convenzione foresees that such National Facilities will be identified through a two-stage consultation process: the first phase addressed to selected stakeholders representing the life science research system, the second to the entire scientific community.
The first phase kicked off on 23 July as a questionnaire was sent to a list of representatives of Universities, research hospitals, research centres, research funding organisations and the life science industry identified by the Convenzione’s Technical Committee. The Committee is composed of two Director Generals of the Ministry of Health and the Ministry of University and Research, one Italian delegate of ESFRI, the Chair of Human Technopole’s Scientific Advisory Board and the Director of Human Technopole.
The questionnaire, largely based on the form used by ESFRI to collect proposals for research infrastructures to be included in the European roadmap, will allow to identify the national life science community’s perceived priorities with regard to research infrastructures and to collect adequately motivated proposals for possible National Facilities to be implemented at Human Technopole.
The indications resulting from this first phase will then be made available for feedback to the Italian scientific community during a second round of consultations to take place in the autumn of 2021.
Documents:
Share:
You could also like:
-
Colorectal Cancer: ML Enhances Cetuximab Response Predictions
An international collaborative study led by Human Technopole, Candiolo Cancer Institute IRCCS in Turin, the University of Turin, and the Wellcome Sanger Institute in Cambridge (UK) has identified new factors associated with therapeutic response in colorectal cancer. The research has led to the development of a machine-learning model capable of accurately predicting the effects of cetuximab, a drug in clinical use, on different colorectal tumour subtypes. Funded by the AIRC Foundation, the study paves the way to identifying molecular features that could serve as biomarkers for predicting treatment response in patients with this type of cancer.
-
Human Technopole Foundation’s Supplier List online
The Human Technopole Foundation’s Supplier Register is now online.
-
HT Director Zerial Awarded Mercurio Prize for Excellence in Research
The Human Technopole Director, Marino Zerial, has been awarded the 2024 Mercurio Prize in the “Research and Development” category, in recognition of the excellence of his research in the field of cell biology. Zerial, renowned for his studies on the mechanisms of endocytosis and cellular transport, has made significant contributions to the understanding of cellular dynamics, with potential therapeutic applications for diseases such as liver conditions.
-
A new model system for cortical development in vitro
Researchers from Human Technopole, the Institute of Molecular Biotechnology and Bicocca University established a method for developing brain assembloids that allows reproducing salient aspects of the antero-posterior polarity of the human cerebral cortex in vitro and opens new possibilities for disease modelling. The study is published in Nature Methods.
-
The National Facility for Genomics with Clelia Peano
Meet Clelia Peano, Head of the National Facility for Genomics. The Facility offers cutting-edge services to develop robust experimental and analytical workflows to explore different genomic research areas, including DNA and RNA analysis, chromatin structure, and epigenetic mechanisms regulating transcription. The goal is to enhance genomic research in all its aspects, benefiting the entire Italian scientific community.